News | August 15, 2014

Texas' First Accredited Pediatric Heart Failure Institute Is Texas Children's Hospital

August 15, 2014 — The Healthcare Accreditation Colloquium announced that Texas Children's Hospital has earned the designation of Accredited Pediatric Heart Failure Institute following 12 months of work and an extensive onsite review.

"The approach to heart failure at Texas Children's Hospital is one of the broadest ranging comprehensive programs in the U.S.," said Frank Smart, Colloquium Board chair. "They care for the sickest children daily, yet remain committed to breakthrough research that has the potential to change medicine for everyone."

The heart failure leadership team at Texas Children's Hospital worked in four domains to achieve heart failure accreditation: The Community, Hospital, Clinician, and Science. In the community their preventative screening program for sudden cardiac arrest in young people was especially notable. The hospital itself is an integrated small city where pediatric patients can actually go to an accredited classroom for their schooling while on ventricular assist devices and after heart transplantation. In the Clinician Domain, physician and nurse education is part of the institutional culture. Novel approaches to practical applications of science are everywhere. One example is the "Just in Time" scenario room where world-class clinicians can come together and practice possible clinical scenarios to prepare themselves anticipating emergencies before they take place.

"The Colloquium is about bringing together experts to improve heart failure care for children across the entire continuum of care," said Dr. Daniel J. Penny, chief of cardiology at Texas Children's Hospital. "We are delighted that Texas Children's is a recognized member of this expert group. We look forward to working with The Colloquium wherever children with heart failure have a need."

The Colloquium is the first organization to develop an improvement science based approach to pediatric heart failure accreditation. Member hospitals conduct the site visits following the guidelines developed by all member hospitals, making the Colloquium's approach to accreditation unique in America. The site reviewers were Frank W. Smart, M.D., FACC, (Colloquium Board Chair) and Sonja H. Dahl, DNP, RN, CPNP, (Heart Failure Leadership Team Coordinator at Mayo Clinic in Rochester, Minn.).

For more information: www.texaschildrens.org


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now